It looks like your browser is not up to date.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

Molecular Templates Inc (MTEM) USD0.001

Sell:$8.29 Buy:$8.33 Change: $0.43 (5.47%)
Market closed |  Prices as at close on 17 May 2021 | Switch to live prices |
Sell:$8.29
Buy:$8.33
Change: $0.43 (5.47%)
Market closed |  Prices as at close on 17 May 2021 | Switch to live prices |
Sell:$8.29
Buy:$8.33
Change: $0.43 (5.47%)
Market closed |  Prices as at close on 17 May 2021 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Molecular Templates, Inc., formerly Threshold Pharmaceuticals, Inc., is a clinical-stage biotechnology company. The Company is engaged in the discovery and development of therapeutic and diagnostic agents that selectively target tumor cells for the treatment of patients living with cancer. The Company also focused on the discovery, development, and commercialization of immunotoxins called engineered toxin bodies (ETBs). The Company is developing two therapeutic product candidates based on hypoxia-activated prodrug technology: evofosfamide and tarloxotinib. The Company’s lead drug candidate MT-3724 is an is an immunotoxin that targets the CD20 cell surface antigen present in a variety of lymphomas and leukemias.

Contact details

Address:
9301 Amberglen Blvd Ste 100
AUSTIN
78729-1153
United States
Telephone:
+1 (512) 8961555
Website:
https://mtem.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
MTEM
ISIN:
US6085501095
Market cap:
$440.85 million
Shares in issue:
56.09 million
Sector:
Biotechnology
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • Harold Selick
    Chairman of the Board
  • Jason Kim
    President, Chief Operating Officer
  • Eric Poma
    Chief Executive Officer, Chief Scientific Officer, Director
  • Adam Cutler
    Chief Financial Officer, Treasurer, Secretary
  • Roger Waltzman
    Chief Medical Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.